Cellectar Biosciences, Inc. (CLRB)

CIK 1279704 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cellectar Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G0001104659-26-096752
Aug 14, 2026SCHEDULE 13G0001727492-26-000017
Aug 14, 2026SCHEDULE 13G0001104659-26-096766
Aug 14, 2026SCHEDULE 13G0001172661-26-003421
Aug 13, 2026SCHEDULE 13G0001420506-26-001621
Aug 13, 20268-K0001104659-26-095460
Aug 13, 202610-Q0001104659-26-095426
Aug 4, 2026SCHEDULE 13G0000919574-26-004748
Jul 10, 20268-K0001104659-26-082719
Jul 10, 20264/A0001104659-26-082761
Jul 8, 202640001104659-26-082012
Jul 8, 202640001104659-26-082011
Jul 8, 202640001104659-26-082016
Jul 8, 202640001104659-26-082013
Jul 8, 202640001104659-26-082010
Jul 8, 202640001104659-26-082014
Jul 8, 202640001104659-26-082015
Jul 8, 202640001104659-26-082009
Jul 8, 202640001104659-26-082018
Jun 9, 202630001104659-26-071893
Jun 5, 2026SCHEDULE 13G0001274173-26-000157
Jun 2, 2026424B30001104659-26-069146
Jun 1, 2026EFFECT9999999995-26-001826
May 29, 2026S-1/A0001104659-26-067933
May 28, 2026DEFA14A0001104659-26-067630